Relugolix combination therapy in European women with symptomatic uterine fibroids: a subgroup analysis from the randomized phase 3 LIBERTY pivotal trials.
Roberta VenturellaAndrzej MalinowskiJános ZatikRachel B WagmanEmily ZhuViatcheslav G RakovFelice PetragliaPublished in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2023)
In European women with UF and HMB, once-daily relugolix-CT vs. placebo improved UF-associated symptoms and preserved BMD.
Keyphrases
- combination therapy
- phase iii
- double blind
- placebo controlled
- open label
- computed tomography
- clinical trial
- physical activity
- contrast enhanced
- dual energy
- image quality
- magnetic resonance imaging
- randomized controlled trial
- sleep quality
- positron emission tomography
- depressive symptoms
- pregnant women
- study protocol
- data analysis